Stryker ROE 2010-2024 | SYK
Current and historical return on equity (ROE) values for Stryker (SYK) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Stryker ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-03-31 | $3.36B | $19.17B | 18.41% |
| 2023-12-31 | $3.17B | $18.59B | 17.89% |
| 2023-09-30 | $2.59B | $17.91B | 15.03% |
| 2023-06-30 | $2.71B | $17.36B | 16.09% |
| 2023-03-31 | $2.63B | $16.90B | 16.01% |
| 2022-12-31 | $2.36B | $16.62B | 14.78% |
| 2022-09-30 | $2.46B | $16.46B | 15.84% |
| 2022-06-30 | $2.08B | $15.67B | 13.91% |
| 2022-03-31 | $2.02B | $15.05B | 13.92% |
| 2021-12-31 | $1.99B | $14.88B | 14.15% |
| 2021-09-30 | $1.90B | $14.18B | 13.92% |
| 2021-06-30 | $2.08B | $13.82B | 15.61% |
| 2021-03-31 | $1.41B | $13.50B | 10.76% |
| 2020-12-31 | $1.60B | $13.08B | 12.31% |
| 2020-09-30 | $1.76B | $12.99B | 13.60% |
| 2020-06-30 | $1.60B | $12.75B | 12.56% |
| 2020-03-31 | $2.16B | $13.12B | 17.25% |
| 2019-12-31 | $2.08B | $12.81B | 17.09% |
| 2019-09-30 | $3.43B | $12.32B | 28.74% |
| 2019-06-30 | $3.55B | $11.94B | 31.40% |
| 2019-03-31 | $3.52B | $11.69B | 32.96% |
| 2018-12-31 | $3.55B | $11.73B | 35.29% |
| 2018-09-30 | $1.24B | $9.86B | 12.83% |
| 2018-06-30 | $1.08B | $9.46B | 11.05% |
| 2018-03-31 | $1.02B | $9.22B | 10.28% |
| 2017-12-31 | $1.02B | $9.98B | 10.16% |
| 2017-09-30 | $1.78B | $10.43B | 17.92% |
| 2017-06-30 | $1.70B | $10.04B | 17.61% |
| 2017-03-31 | $1.69B | $9.70B | 17.93% |
| 2016-12-31 | $1.65B | $9.55B | 17.91% |
| 2016-09-30 | $1.66B | $9.33B | 18.56% |
| 2016-06-30 | $1.61B | $9.10B | 18.39% |
| 2016-03-31 | $1.62B | $8.81B | 18.85% |
| 2015-12-31 | $1.44B | $8.51B | 17.02% |
| 2015-09-30 | $1.18B | $8.48B | 13.89% |
| 2015-06-30 | $0.93B | $8.51B | 10.96% |
| 2015-03-31 | $0.67B | $8.32B | 7.75% |
| 2014-12-31 | $0.52B | $8.60B | 5.84% |
| 2014-09-30 | $0.64B | $8.62B | 7.17% |
| 2014-06-30 | $0.69B | $9.00B | 7.67% |
| 2014-03-31 | $0.77B | $9.06B | 8.71% |
| 2013-12-31 | $1.01B | $9.05B | 11.55% |
| 2013-09-30 | $0.89B | $8.74B | 10.35% |
| 2013-06-30 | $1.14B | $8.60B | 13.41% |
| 2013-03-31 | $1.25B | $8.46B | 15.01% |
| 2012-12-31 | $1.30B | $8.60B | 15.77% |
| 2012-09-30 | $1.43B | $8.36B | 17.85% |
| 2012-06-30 | $1.40B | $7.95B | 17.98% |
| 2012-03-31 | $1.39B | $8.02B | 17.89% |
| 2011-12-31 | $1.35B | $7.68B | 17.66% |
| 2011-09-30 | $1.24B | $7.56B | 16.54% |
| 2011-06-30 | $1.25B | $7.78B | 16.82% |
| 2011-03-31 | $1.26B | $7.45B | 17.55% |
| 2010-12-31 | $1.27B | $7.17B | 18.25% |
| 2010-09-30 | $1.28B | $7.31B | 18.80% |
| 2010-06-30 | $1.18B | $6.75B | 17.78% |
| 2010-03-31 | $1.15B | $6.67B | 17.82% |
| 2009-12-31 | $1.11B | $6.60B | 17.91% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $129.352B | $20.498B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.514B | 24.03 |
| Boston Scientific (BSX) | United States | $113.715B | 36.22 |
| Medtronic (MDT) | Ireland | $103.107B | 15.43 |
| EssilorLuxottica (ESLOY) | France | $101.762B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.392B | 0.00 |
| Haleon (HLN) | United Kingdom | $39.132B | 28.57 |
| ResMed (RMD) | United States | $27.007B | 25.36 |
| Terumo (TRUMY) | Japan | $24.269B | 34.27 |
| Koninklijke Philips (PHG) | Netherlands | $23.059B | 18.30 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.264B | 14.22 |
| Baxter (BAX) | United States | $17.305B | 12.30 |
| Insulet (PODD) | United States | $14.411B | 63.90 |
| Demant (WILYY) | Denmark | $10.984B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.877B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.994B | 26.14 |
| BellRing Brands (BRBR) | United States | $7.556B | 35.54 |
| Lantheus Holdings (LNTH) | United States | $5.677B | 14.15 |
| GN Store Nord (GNNDY) | Denmark | $4.364B | 24.51 |
| Haemonetics (HAE) | United States | $4.251B | 20.96 |
| Perrigo (PRGO) | Ireland | $3.490B | 10.58 |
| Neogen (NEOG) | United States | $3.487B | 33.54 |
| Prestige Consumer Healthcare (PBH) | United States | $3.449B | 16.41 |
| TG Therapeutics (TGTX) | United States | $2.966B | 83.43 |
| ICU Medical (ICUI) | United States | $2.799B | 24.70 |
| Envista Holdings (NVST) | United States | $2.750B | 11.35 |
| Green Thumb Industries (GTBIF) | United States | $2.568B | 50.27 |
| Agios Pharmaceuticals (AGIO) | United States | $2.537B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.203B | 12.23 |
| LeMaitre Vascular (LMAT) | United States | $1.838B | 53.87 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.731B | 0.00 |
| Warby Parker (WRBY) | United States | $1.558B | 0.00 |
| InMode (INMD) | Israel | $1.512B | 8.04 |
| AdaptHealth (AHCO) | United States | $1.289B | 9.58 |
| Verano Holdings (VRNOF) | United States | $1.266B | 0.00 |
| Owens & Minor (OMI) | United States | $1.179B | 10.27 |
| AtriCure (ATRC) | United States | $1.013B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.006B | 32.00 |
| BioLife Solutions (BLFS) | United States | $0.984B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.771B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.710B | 15.12 |
| PetIQ (PETQ) | United States | $0.656B | 21.21 |
| Evolus (EOLS) | United States | $0.654B | 0.00 |
| Surmodics (SRDX) | United States | $0.598B | 37.46 |
| VAREX IMAGING (VREX) | United States | $0.590B | 13.88 |
| Valneva SE (VALN) | France | $0.520B | 0.00 |
| ZimVie (ZIMV) | United States | $0.495B | 42.21 |
| Canopy Growth (CGC) | Canada | $0.494B | 0.00 |
| Quanterix (QTRX) | United States | $0.485B | 0.00 |
| Biote (BTMD) | United States | $0.449B | 10.33 |
| Jin Medical (ZJYL) | China | $0.432B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.417B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.312B | 10.05 |
| Cerus (CERS) | United States | $0.311B | 0.00 |
| Zynex (ZYXI) | United States | $0.274B | 37.52 |
| MacroGenics (MGNX) | United States | $0.269B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.257B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.247B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.245B | 24.31 |
| Sanara MedTech (SMTI) | United States | $0.243B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.237B | 14.90 |
| Omeros (OMER) | United States | $0.225B | 0.00 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.155B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.153B | 21.70 |
| TriSalus Life Sciences (TLSI) | United States | $0.151B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.148B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.140B | 67.00 |
| Quipt Home Medical (QIPT) | United States | $0.130B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.126B | 0.00 |
| Veru (VERU) | United States | $0.116B | 0.00 |
| Brainsway (BWAY) | Israel | $0.104B | 0.00 |
| InterCure (INCR) | Israel | $0.099B | 16.77 |
| Fonar (FONR) | United States | $0.099B | 10.00 |
| Cellectar Biosciences (CLRB) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.090B | 0.00 |
| Chimerix (CMRX) | United States | $0.083B | 0.00 |
| MariMed (MRMD) | United States | $0.072B | 0.00 |
| Bright Green (BGXX) | United States | $0.061B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
| Safety Shot (SHOT) | United States | $0.054B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.050B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.25 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.035B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |